1.Controversial issues in radiotherapy for rectal cancer: a systematic review.
Radiation Oncology Journal 2017;35(4):295-305
The role of radiotherapy (RT) as an adjuvant to surgical options in the treatment of locally advanced rectal cancer has been established as it reduces local recurrence when combined with surgical resection and enhances survival when used in multidisciplinary treatment. However, many issues need to be addressed; some of these can render RT unnecessary, whereas others can reveal a new role of RT in rectal cancer. This review will discuss not only the basic role of RT but also the associated but controversial issues in detail in an attempt to find answers and determine future directions for the next decade.
Radiotherapy*
;
Rectal Neoplasms*
;
Recurrence
2.A phase II trial of combined sequential FP (5-FU+cisplatin) chemotheraphy and radiotherapy in locally advanced unresectable esophageal cancer.
Jong Won HA ; Hyun Cheol CHUNG ; Dong Lip KIM ; Jin Hyuk CHOI ; Nae Choon YOO ; Eun Hee KOH ; Joo Hang KIM ; Jae Kyung ROH ; Gwi Eon KIM ; John Kyu LOH JUHN ; Byung Soo KIM
Journal of the Korean Cancer Association 1991;23(2):307-314
No abstract available.
Esophageal Neoplasms*
;
Radiotherapy*
3.Vitexin promotes the recovery of some biological indices in breast cancer patients after radiotherapy
Journal of Medicinal Materials - Hanoi 2005;10(5):149-153
Study on 74 breast cancer patients after radiotherapy in K Hospital, Hanoi. Results: Vitexin capsule decreased the lesion of leukocyte cells after radiotherapy compared with control group. After radiotherapy, TCD4, TCD8 lymphocytes decreased statistical significantly in comparison with before treatment. After taking drug for 2 months (4 capsules/day, 100mg/capsule divided 2 times), the cells were being recovery with different levels, the number of TCD8 in Vitexin group was higher than those in the control group. The findings suggested that the Vitexin had ability to recover quickly the numerous of damaged immune cells during radiotherapy
Breast Neoplasms
;
Apigenin
;
Radiotherapy
4.Safe Distal Resection Margin in Patients With T3 Mid and Distal Rectal Cancer Who Underwent a Sphincter-Saving Resection Without Preoperative Radiotherapy.
Bong Hwa LEE ; Hyoung Chul PARK ; Min Jeong KIN ; Mi Young JANG
Annals of Coloproctology 2013;29(6):219-220
No abstract available.
Humans
;
Radiotherapy*
;
Rectal Neoplasms*
5.Radiotherapy of Esophagus Cancer, with Special Reference to Upper Third.
Sung Beam BAN ; Myung Sun CHOI
Journal of the Korean Society for Therapeutic Radiology 1984;2(2):299-301
No abstract available.
Esophageal Neoplasms*
;
Esophagus*
;
Radiotherapy*
6.Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer.
Annals of Coloproctology 2016;32(2):47-48
No abstract available.
Colorectal Neoplasms*
;
Humans
;
Radiotherapy*
7.Failure anaysis of radical radiotherapy in laryngeal cancer.
Korean Journal of Otolaryngology - Head and Neck Surgery 1993;36(2):225-233
No abstract available.
Laryngeal Neoplasms*
;
Radiotherapy*
8.A dysfunctional Larynx dilemma: Carcinoma recurrence or radiation-induced damage?
Patricia Ann U. Soriano ; Arsenio Claro A. Cabungcal ; Cesar Vincent L. Villafuerte III ; Anna Claudine F. Lahoz
Acta Medica Philippina 2020;54(Online):1-5
A 61-year-old male diagnosed with laryngeal squamous cell carcinoma presented with hoarseness, progressive
dysphagia leading to aspiration, and dyspnea one month after definitive radiation therapy. Examination revealed a diffusely swollen glottis, paralyzed vocal cords, and post-radiation fibrosis. Several glottic biopsies yielded results negative for malignancy and favored radiation-induced changes. When presented with the option of further diagnostic testing with a positron emission tomography (PET) scan or an outright laryngectomy, the patient decided on the latter. Final histopathologic diagnosis was negative for recurrence of malignancy.
This case demonstrates treatment dilemmas for patients with laryngeal carcinoma with uncertain recurrence wherein radical surgical management may prove to be a viable option to achieve both diagnostic certainty and ultimate relief of symptoms.
Laryngeal Neoplasms
;
Laryngectomy
;
Radiotherapy
9.A dysfunctional larynx dilemma: Carcinoma recurrence or radiation-induced damage?
Patricia Ann U. Soriano ; Arsenio Claro A. Cabungcal ; Cesar Vincent L. Villafuerte, III ; Anna Claudine F. Lahoz
Acta Medica Philippina 2023;57(11):97-101
A 61-year-old male diagnosed with laryngeal squamous cell carcinoma presented with hoarseness, progressive dysphagia leading to aspiration, and dyspnea one month after definitive radiation therapy. Examination revealed a diffusely swollen glottis, paralyzed vocal cords, and post-radiation fibrosis. Several glottic biopsies yielded results negative for malignancy and favored radiation-induced changes. When presented with the option of further diagnostic testing with a positron emission tomography (PET) scan or an outright laryngectomy, the patient decided on the latter. Final histopathologic diagnosis was negative for recurrence of malignancy.
This case demonstrates treatment dilemmas for patients with laryngeal carcinoma with uncertain recurrence wherein radical surgical management may prove to be a viable option to achieve both diagnostic certainty and ultimate relief of symptoms.
Laryngeal Neoplasms
;
Laryngectomy
;
Radiotherapy
10.Is the Use of Intensity-Modulated Radiotherapy Beneficial for Pancreatic Cancer Patients?.
Gut and Liver 2016;10(2):164-165
No abstract available.
Humans
;
Pancreatic Neoplasms/*radiotherapy
;
*Radiotherapy, Intensity-Modulated